Skin Elements Limited (ASX:SKN)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Biotechnology sector focused on developing of its proprietary SE Formula	469.96K	416.20K	194.13K	-	-
Biotechnology sector focused on developing of its proprietary SE Formula Growth	12.92%	114.39%	-	-	-
Operations	-	-	-	1.41M	288.74K
Operations Growth	-	-	-	387.75%	-32.09%
Total	469.96K	416.20K	194.13K	1.41M	288.74K
Total Growth	12.92%	114.39%	-86.22%	387.75%	-32.09%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Australia	469.96K	416.20K	194.13K	1.41M	288.74K
Australia Growth	12.92%	114.39%	-86.22%	387.75%	-32.09%
Total	469.96K	416.20K	194.13K	1.41M	288.74K
Total Growth	12.92%	114.39%	-86.22%	387.75%	-32.09%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 15, 2026

Data Sources Report a data error